SGAMBELLONE, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 636
EU - Europa 599
AS - Asia 195
AF - Africa 7
OC - Oceania 6
SA - Sud America 5
Totale 1.448
Nazione #
US - Stati Uniti d'America 628
RU - Federazione Russa 222
PL - Polonia 114
IT - Italia 95
SG - Singapore 51
IE - Irlanda 46
SE - Svezia 44
HK - Hong Kong 39
CN - Cina 36
CH - Svizzera 26
DE - Germania 18
IN - India 16
JO - Giordania 12
KR - Corea 11
GB - Regno Unito 8
AU - Australia 6
CA - Canada 6
NL - Olanda 6
TW - Taiwan 6
VN - Vietnam 6
FR - Francia 5
BE - Belgio 4
EG - Egitto 4
FI - Finlandia 4
IR - Iran 4
SY - Repubblica araba siriana 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BR - Brasile 3
JP - Giappone 3
UA - Ucraina 3
CI - Costa d'Avorio 2
CL - Cile 2
MX - Messico 2
PK - Pakistan 2
TR - Turchia 2
DK - Danimarca 1
ZA - Sudafrica 1
Totale 1.448
Città #
Santa Clara 178
Warsaw 113
Fairfield 73
Singapore 45
Dublin 44
Chandler 42
Ashburn 28
Woodbridge 24
Bern 23
Hong Kong 21
Houston 21
Seattle 21
Florence 19
Wilmington 19
Altamura 18
Lawrence 18
Cambridge 15
Moscow 14
Kent 11
Buffalo 9
Princeton 9
Mumbai 8
Seoul 8
Beijing 7
Boston 6
Los Angeles 6
Medford 5
Sesto Fiorentino 5
Ann Arbor 4
Boardman 4
Cagliari 4
Delhi 4
Dong Ket 4
London 4
New York 4
San Diego 4
West Jordan 4
Al Ain City 3
Brussels 3
Central 3
Giza 3
Helsinki 3
Montreal 3
Paris 3
Perth 3
Queens 3
Rio Branco 3
Rome 3
San Jose 3
Shahin Shahr 3
Taipei 3
Vienna 3
Zurich 3
Abidjan 2
Adana 2
Alessandria 2
Amsterdam 2
Berlin 2
Brisbane 2
Castelliri 2
Düsseldorf 2
Essen 2
Falls Church 2
Fiesole 2
Hefei 2
Lahore 2
Lampa 2
Lviv 2
Malvern 2
Melesse 2
Munich 2
Nanjing 2
Naples 2
Neunkirchen 2
Osan 2
Phoenix 2
Prato 2
Puebla City 2
Rochester 2
Scarperia e San Piero 2
Shanghai 2
Tokyo 2
Tübingen 2
Verona 2
Victoria 2
Yubileyny 2
Zhengzhou 2
Andover 1
Atlanta 1
Baltimore 1
Bhubaneswar 1
Cairo 1
Cape Town 1
Castelfranco Emilia 1
Chengdu 1
Chicago 1
Chiswick 1
Copenhagen 1
Dongguan 1
East Lansing 1
Totale 975
Nome #
Histamine H3 receptor (H3R) antagonist-Nitric Oxide (NO) donor hybrid compounds as a new therapeutic strategy for the treatment of glaucoma and retinal neuroprotection 210
Role of histamine H3 receptor antagonists on intraocular pressure reduction in rabbit models of transient ocular hypertension and glaucoma 176
Effects of PARP-1 deficiency and histamine H4receptor inhibition in an inflammatory model of lung fibrosis in mice 173
Discovery of β-Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy 131
Effects of new nsaid-cai hybrid compounds in inflammation and lung fibrosis 98
2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and antiglaucoma activity 96
Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of Action 93
D-Tagatose Feeding Reduces the Risk of Sugar-Induced Exacerbation of Myocardial I/R Injury When Compared to Its Isomer Fructose 92
CNS-Sparing Histamine H3 Receptor Antagonist as a Candidate to Prevent the Diabetes-Associated Gastrointestinal Symptoms 65
One-Pot Procedure for the Synthesis of Asymmetric Substituted Ureido Benzene Sulfonamides as Effective Inhibitors of Carbonic Anhydrase Enzymes 62
The histamine h4 receptor participates in the anti-neuropathic effect of the adenosine a3 receptor agonist ib-meca: Role of cd4+ t cells 59
NCX 470 Restores Ocular Hemodynamics and Retinal Cell Physiology After ET-1-Induced Ischemia/Reperfusion Injury of Optic Nerve and Retina in Rabbits 58
NCX 470 Exerts Retinal Cell Protection and Enhances Ophthalmic Artery Blood Flow After Ischemia/Reperfusion Injury of Optic Nerve Head and Retina 53
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit 45
Novel Carbonic Anhydrase Inhibitors with Dual-Tail Core Sulfonamide Show Potent and Lasting Effects for Glaucoma Therapy 42
Adenosine A3 Receptor (A3AR) Agonist for the Treatment of Bleomycin-Induced Lung Fibrosis in Mice 18
Totale 1.471
Categoria #
all - tutte 5.622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.622


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020128 0 0 0 0 23 21 16 21 18 12 12 5
2020/2021135 9 9 1 10 26 13 4 4 17 21 13 8
2021/202288 0 0 2 2 1 11 18 9 3 10 18 14
2022/2023279 17 56 16 8 16 37 26 18 33 6 12 34
2023/2024203 9 13 17 5 12 20 10 32 9 23 36 17
2024/2025595 48 93 85 138 231 0 0 0 0 0 0 0
Totale 1.471